FDA Drug Application (204683) for KHEDEZLA by OSMOTICA PHARM CORP

Back to FDA Applications sponsored by OSMOTICA PHARM CORP

Application Number204683
Product Number001
FormTABLET, EXTENDED RELEASE;ORAL
Dosage50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code BC Extended-release dosage forms (capsules, injectables and tablets)
Reference Drug
Drug NameKHEDEZLA
Active IngredientDESVENLAFAXINE



Back to FDA Applications sponsored by OSMOTICA PHARM CORP

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.